Fingerpaint Medical Communications

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Fingerpaint Medical Communications - overview

Location

Morristown, NJ, US

Primary Industry

Marketing/Advertising

About

Based in New Jersey, US, Fingerpaint Medical Communications, formerly known as PharmaHEALTHLabs, is a scientific healthcare communications agency that specializes in the oncology and biologics space that provides deep human and scientific insights. In March 2023, Fingerpaint Marketing Inc. , a portfolio company of Knox Lane, acquired PharmaHEALTHLabs. The company offers market research, advertising, data-led digital media, product re-branding, consulting on gene and cell therapy, marketing communications, including branded professional and consumer promotion, product promotion, and other public services.


Current Investors

Fingerpaint Group

Primary Industry

Marketing/Advertising

Sub Industries

Public Relations & Communications, Market Research & Consulting, Advertising Agencies & Media Buyers, Healthcare

Website

www.fingerpaintmedcomms.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Fingerpaint Medical Communications - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedFingerpaint Medical Communications-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.